Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Oral Anticoagulant Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Warfarin
  • 1.3.3 Dabigatran
  • 1.3.4 Rivaroxaban
  • 1.3.5 Others
• 1.4 Market Segment by Application
  • 1.4.1 Global Oral Anticoagulant Market Share by Application (2019-2025)
  • 1.4.2 Thromboembolic Disease
  • 1.4.3 Disseminated Intravascular Coagulation
  • 1.4.4 Cardiovascular Surgery
  • 1.4.5 Others
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Oral Anticoagulant Market Size
  • 2.1.1 Global Oral Anticoagulant Revenue 2014-2025
  • 2.1.2 Global Oral Anticoagulant Sales 2014-2025
• 2.2 Oral Anticoagulant Growth Rate by Regions
  • 2.2.1 Global Oral Anticoagulant Sales by Regions 2014-2019
  • 2.2.2 Global Oral Anticoagulant Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Oral Anticoagulant Sales by Manufacturers
  • 3.1.1 Oral Anticoagulant Sales by Manufacturers 2014-2019
  • 3.1.2 Oral Anticoagulant Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Oral Anticoagulant Revenue by Manufacturers (2014-2019)
  • 3.2.2 Oral Anticoagulant Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Oral Anticoagulant Market Concentration Ratio (CR5 and HHI)
• 3.3 Oral Anticoagulant Price by Manufacturers
• 3.4 Key Manufacturers Oral Anticoagulant Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Oral Anticoagulant Market
• 3.6 Key Manufacturers Oral Anticoagulant Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Warfarin Sales and Revenue (2014-2019)
  • 4.1.2 Dabigatran Sales and Revenue (2014-2019)
  • 4.1.3 Rivaroxaban Sales and Revenue (2014-2019)
  • 4.1.4 Others Sales and Revenue (2014-2019)
• 4.2 Global Oral Anticoagulant Sales Market Share by Type
• 4.3 Global Oral Anticoagulant Revenue Market Share by Type
• 4.4 Oral Anticoagulant Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Oral Anticoagulant Sales by Application

6 United States

• 6.1 United States Oral Anticoagulant Breakdown Data by Company
• 6.2 United States Oral Anticoagulant Breakdown Data by Type
• 6.3 United States Oral Anticoagulant Breakdown Data by Application

7 European Union

• 7.1 European Union Oral Anticoagulant Breakdown Data by Company
• 7.2 European Union Oral Anticoagulant Breakdown Data by Type
• 7.3 European Union Oral Anticoagulant Breakdown Data by Application

8 China

• 8.1 China Oral Anticoagulant Breakdown Data by Company
• 8.2 China Oral Anticoagulant Breakdown Data by Type
• 8.3 China Oral Anticoagulant Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Oral Anticoagulant Breakdown Data by Company
• 9.2 Rest of World Oral Anticoagulant Breakdown Data by Type
• 9.3 Rest of World Oral Anticoagulant Breakdown Data by Application
• 9.4 Rest of World Oral Anticoagulant Breakdown Data by Countries
  • 9.4.1 Rest of World Oral Anticoagulant Sales by Countries
  • 9.4.2 Rest of World Oral Anticoagulant Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Akers Biosciences
  • 10.1.1 Akers Biosciences Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Oral Anticoagulant
  • 10.1.4 Oral Anticoagulant Product Introduction
  • 10.1.5 Akers Biosciences Recent Development
• 10.2 Pfizer
  • 10.2.1 Pfizer Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Oral Anticoagulant
  • 10.2.4 Oral Anticoagulant Product Introduction
  • 10.2.5 Pfizer Recent Development
• 10.3 Eisai
  • 10.3.1 Eisai Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Oral Anticoagulant
  • 10.3.4 Oral Anticoagulant Product Introduction
  • 10.3.5 Eisai Recent Development
• 10.4 AstraZeneca
  • 10.4.1 AstraZeneca Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Oral Anticoagulant
  • 10.4.4 Oral Anticoagulant Product Introduction
  • 10.4.5 AstraZeneca Recent Development
• 10.5 Eli Lilly
  • 10.5.1 Eli Lilly Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Oral Anticoagulant
  • 10.5.4 Oral Anticoagulant Product Introduction
  • 10.5.5 Eli Lilly Recent Development
• 10.6 Medicure
  • 10.6.1 Medicure Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Oral Anticoagulant
  • 10.6.4 Oral Anticoagulant Product Introduction
  • 10.6.5 Medicure Recent Development
• 10.7 GlaxoSmithKline
  • 10.7.1 GlaxoSmithKline Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Oral Anticoagulant
  • 10.7.4 Oral Anticoagulant Product Introduction
  • 10.7.5 GlaxoSmithKline Recent Development
• 10.8 Novartis AG
  • 10.8.1 Novartis AG Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Oral Anticoagulant
  • 10.8.4 Oral Anticoagulant Product Introduction
  • 10.8.5 Novartis AG Recent Development
• 10.9 Sanofi
  • 10.9.1 Sanofi Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Oral Anticoagulant
  • 10.9.4 Oral Anticoagulant Product Introduction
  • 10.9.5 Sanofi Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Oral Anticoagulant Sales Channels
  • 11.2.2 Oral Anticoagulant Distributors
• 11.3 Oral Anticoagulant Customers

12 Market Forecast

• 12.1 Global Oral Anticoagulant Sales and Revenue Forecast 2019-2025
• 12.2 Global Oral Anticoagulant Sales Forecast by Type
• 12.3 Global Oral Anticoagulant Sales Forecast by Application
• 12.4 Oral Anticoagulant Forecast by Regions
  • 12.4.1 Global Oral Anticoagulant Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Oral Anticoagulant Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

In 2019, the market size of Oral Anticoagulant is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Oral Anticoagulant.

This report studies the global market size of Oral Anticoagulant, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Oral Anticoagulant sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Akers Biosciences
Pfizer
Eisai
AstraZeneca
Eli Lilly
Medicure
GlaxoSmithKline
Novartis AG
Sanofi

Market Segment by Product Type
Warfarin
Dabigatran
Rivaroxaban
Others

Market Segment by Application
Thromboembolic Disease
Disseminated Intravascular Coagulation
Cardiovascular Surgery
Others

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Oral Anticoagulant status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Oral Anticoagulant manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Oral Anticoagulant are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025